Cheyne Capital Management (UK) LLP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 123 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$404,000
-69.0%
70,000
-56.2%
0.19%
-55.2%
Q2 2015$1,305,000
+219.9%
160,000
+220.0%
0.42%
+330.6%
Q1 2015$408,00050,0000.10%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 200,000$998,0000.36%
Green Alpha Advisors, LLC 72,647$363,0000.24%
Skaana Management L.P. 227,851$1,137,0000.18%
SEVEN EIGHT CAPITAL, LP 196,351$980,0000.18%
Defender Capital, LLC. 103,038$514,0000.16%
Skaana Management L.P. 206,300$1,029,0000.16%
WASATCH ADVISORS LP 4,926,125$24,581,0000.10%
Parametrica Management Ltd 16,183$81,0000.08%
Cedar Brook Financial Partners, LLC 54,500$272,0000.07%
Hennion & Walsh Asset Management, Inc. 274,703$1,371,0000.07%
View complete list of INOVIO PHARMACEUTICALS INC shareholders